Clariant signs definitive agreement to sell Quats business
MUTTENZ,AUGUST 31, 2022
Clariant, a focused, sustainable, and innovative specialty chemical company, today announced that it has reached a definitive agreement for the divestment of its Quats business to Global Amines Company Pte. Ltd., a 50/50 joint venture owned by Clariant and Wilmar, Asia’s leading agricultural business and oleochemicals business globally.
This divestment is a further step in Clariant’s portfolio transformation to focus operations purely on specialty chemicals. Quats are quaternary ammonium compounds, a group of chemicals used for a variety of purposes including as preservatives, surfactants, and as antistatic agents. Quats are used in a wide range of commercial, industrial, and consumer products. The business maintains an excellent reputation as a leading supplier of quats with proprietary technology and a good service reputation.
The transfer will be an asset sale of the sites in Germany, Indonesia, and Brazil and will provide for tolling agreements where needed. The sales price, subject to standard closing conditions, is set at USD 113 million. The transaction is subject to regulatory approvals and customary closing conditions. The transaction is expected to be consummated in the first half of 2023.
|CORPORATE MEDIA RELATIONS|
Phone +41 61 469 63 63
Phone +41 61 469 63 63
Phone +41 61 469 63 63
Phone +41 61 469 63 73
Phone +41 61 469 63 73
Phone +41 61 469 63 73
|Follow us on Twitter, Facebook, LinkedIn, Instagram.|
This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.
Clariant is a focused, sustainable, and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2021, Clariant totaled a staff number of 11 537 and recorded sales of CHF 4.372 billion in the fiscal year for its continuing businesses. The company reports in three Business Areas: Care Chemicals, Catalysis, and Natural Resources. Clariant’s corporate strategy is led by the overarching purpose of ‘Greater chemistry – between people and planet,’ and reflects the importance of connecting customer focus, innovation, sustainability, and people.
- Clariant Media Release_Divestment Quats Business_20220831_EN
- Clariant Media Release_Divestment Quats Business_20220831_DE
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Mohawk Industries, Inc. Invites You to Join the Third Quarter 2022 Earnings Conference Call5.10.2022 22:01:23 CEST | Press release
CALHOUN, Ga., Oct. 05, 2022 (GLOBE NEWSWIRE) -- In conjunction with Mohawk Industries, Inc. (NYSE: MHK) Third Quarter 2022 earnings release on Thursday October 27, 2022, you are invited to listen to the conference call that will be broadcast live on Friday October 28, 2022 at 11:00 am ET. What:Mohawk Industries, Inc. 3rd Quarter 2022 Earnings CallWhen:October 28, 202211:00 am ETWhere:www.mohawkind.comSelect Investor InformationHow:Live over the Internet – Simply log on to the web at the address above orRegister for the conference call at https://dpregister.com/sreg/10171853/f4b0080751Live Conference Call:Dial 1-833-630-1962 (US/Canada)Dial 1-412-317-1843 (Int’l) Mohawk Industries is the leading global flooring manufacturer that creates products to enhance residential and commercial spaces around the world. Mohawk’s vertically integrated manufacturing and distribution processes provide competitive advantages in the production of carpet, rugs, ceramic tile, laminate, wood, stone and viny
REPURCHASE OF SHARES5.10.2022 20:00:00 CEST | Press release
REPURCHASE OF SHARES Amsterdam, the Netherlands - Flow Traders N.V. (“Flow Traders”) (Euronext: FLOW) has repurchased 54,950of its own shares in the period from 29September 2022 up to and including 5October 2022 at an average price of €19.28. This is in accordance with the share buyback programme announced on 22 July 2022. The consideration of this purchase was €1.1 million. The total number of shares purchased under this programme to date is 337,152 shares at an average price of €19.43 for a total consideration of €6.6 million. 3,127,247 shares were held in treasury as at 5 October 2022. Contact Details Flow Traders N.V. Jonathan Berger / Investor Relations Officer Phone: +31 20 7996799 Email: email@example.com About Flow Traders Flow Traders is a leading global financial technology-enabled liquidity provider in financial products, historically specialized in Exchange Traded Products (ETPs), now expanding into other asset classes. Flow Traders ensures the provision of
Dovre's Suvic Oy has signed a contract for the foundation construction of two new wind farms5.10.2022 17:00:00 CEST | Press release
Dovre Group Plc Press release October 5, 2022 at 6 pm Dovre's Suvic Oy has signed a contract for the foundation construction of two new wind farms Suvic has signed a design and construction agreement for constructing the foundations for two new wind farms in Ostrobothnia in the municipality of Ii. The new wind farms will be called Isokangas and Palokangas. The design work will start by the end of 2022 and the construction work will commence in the spring of 2023. The owner of the project is Exilion Tuuli, which is an investment company owned by Elo, The State Pension Fund of Finland and Veritas. Isokangas and Palokangas will together have 17 windmills with a total capacity of 100 MW. "We are very happy to start cooperation with a new Finnish customer Exilion Oy", states Suvic Oy's CEO and Chairman of the Board Mr. Ville Vesanen. Additional information: Suvic Oy Ville Vesanen CEO Tel. +358 44 328 9928 firstname.lastname@example.org, www.suvic.fi Suvic Oy is a Finnish construction company founded in 2017
Evaxion welcomes Per Norlén as new CEO.5.10.2022 14:32:40 CEST | Press release
COPENHAGEN, Denmark, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announces that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd. Dr. Norlén is a board-certified physician and associate professor with more than 20 years in the biotech sector, of which the last decade has been in executive leadership roles. He brings a wealth of experience from being CEO of listed drug development companies. He has a proven business development track record, including major out-licensing deals with biotech and Pharma. “Evaxion has emerged from being an under-the-radar start-up to becoming a clinical stage biotech company leading the development of tailored cancer immunotherapies, individually designed for each patient. I am convinced that Evaxion is on to something extremely important that holds the potential to
UPM inaugurates its new deep sea pulp terminal in the Port of Montevideo5.10.2022 14:00:00 CEST | Press release
(UPM, Helsinki, 5 October 2022 at 15:00 EEST) – UPM inaugurates today its new pulp terminal in the port of Montevideo, Uruguay. This investment of approximately USD 280 million is a fundamental part of UPM’s USD 3.47 billion growth investment in Uruguay that includes a state-of-the-art pulp mill in Paso de los Toros, new eucalyptus tree nursery as well as local community investments in Paso de los Toros. “This is a significant milestone in our growth project in Uruguay. The new pulp terminal with direct connections from the new pulp mill and to the global markets plays a key role in the growth and competitiveness of UPM’s pulp business,” says UPM President and CEO JussiPesonen. “The public infrastructure investments to the deep sea port and railway improve the competitiveness of all export sectors in Uruguay.” The new pulp terminal is located in the newly developed deep sea port in Montevideo, and it will have a direct rail connection to the new UPM Paso de los Toros mill. In the futur